Medical Device Equivalence Analysis Examines 2 Factors
A couple of weeks ago the U.S. Food and Drug Administration issued draft guidance, the "Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications [510(k)] with Different Technological Characteristics."...To view the full article, register now.
Already a subscriber? Click here to view full article